Article Information
History
- December 26, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Ashley D. Otter1,*,†,
- Scott Jones1,*,
- Bethany Hicks1,*,
- Daniel Bailey2,
- Helen Callaby2,
- Catherine Houlihan2,
- Tommy Rampling2,
- Nicola Claire Gordon2,
- Hannah Selman1,
- Panayampalli S. Satheshkumar3,
- Michael Townsend3,
- Ravi Mehta4,
- Marcus Pond5,
- Rachael Jones5,
- Deborah Wright6,
- Clarissa Oeser7,
- Simon Tonge8,
- Ezra Linley8,
- Georgia Hemingway1,
- Tom Coleman1,
- Sebastian Millward1,
- Aaron Lloyd1,
- Inger Damon3,
- Tim Brooks2,
- Richard Vipond6,
- Cathy Rowe1 and
- Bassam Hallis6
- 1Emerging Pathogen Serology group, UKHSA Porton Down, Wiltshire, UK
- 2Rare and Imported Pathogens Laboratory, UKHSA Porton Down, Wiltshire, UK
- 3Poxvirus and Rabies Branch, Centre for Disease Control and Prevention, Atlanta, Georgia, USA
- 4Imperial College Health Trust, London, UK
- 5Chelsea and Westminster Health Trust, London, UK
- 6Research and Development, UKHSA Porton Down, Wiltshire, UK
- 7Immunisation and Vaccine Preventable Diseases Division, UKHSA Colindale, London, UK
- 8Seroepidemiology Unit, UKHSA Manchester, Manchester, UK
- ↵†corresponding author: ashley.otter{at}ukhsa.gov.uk
↵* contributed equally